welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!
terminated

Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD)

key information

study id #: NCT02858362

condition: Duchenne Muscular Dystrophy

status: terminated

purpose:

To Assess the Activity and Safety of SMT C1100 (Ezutromid) in Paediatric Male Participants with Duchenne Muscular Dystrophy (DMD).

intervention: ezutromid

mechanism of action: Utophin modulator to promote utophin production

results: https://clinicaltrials.gov/ct2/show/results/NCT02858362

last updated: January 17, 2020

rareRelated